SCHEMBL2448842

SCHEMBL2448842

O=Cc1cccc2nc3ccccc3cc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 7/20 0.55
KMT2A Q03164 7/20 0.55
ALDH1A1 P00352 6/20 0.55
HPGD P15428 5/20 0.55
GAA P10253 4/20 0.55
KDM4E B2RXH2 4/20 0.55
RAB9A P51151 3/20 0.55
GLA P06280 2/20 0.55
POLB P06746 2/20 0.55
NPC1 O15118 1/20 0.55
PTBP1 P26599 1/20 0.55
RCE1 Q9Y256 1/20 0.55
MAPT P10636 5/20 0.50
ACHE P22303 1/20 0.50
MEN1 O00255 5/20 0.43
THRB P10828 1/20 0.43
BLM P54132 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
HTT P42858 3/20 0.41
NPSR1 Q6W5P4 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridine SCHEMBL27715747 0.92 ALDH1A1 (0.47) LMNAKMT2AALDH1A1HPGDGAA
Quinoline SCHEMBL27619023 0.89 ALDH1A1 (0.50) LMNAKMT2AALDH1A1HPGDGAA
SCHEMBL27953099 0.86 LMNA (0.49) LMNAKMT2AALDH1A1HPGDGAA
SCHEMBL30044538 0.81 ALDH1A1 (0.55) LMNAKMT2AALDH1A1HPGDGAA
SCHEMBL291404 0.81 ALDH1A1 (0.55) LMNAKMT2AALDH1A1HPGDGAA
SCHEMBL28369826 0.81 KDM4E (0.55) LMNAKMT2AALDH1A1HPGDGAA
SCHEMBL6008038 0.81 KDM4E (0.55) LMNAKMT2AALDH1A1HPGDGAA
SCHEMBL738321 0.81 ALDH1A1 (0.55) LMNAKMT2AALDH1A1HPGDGAA
SCHEMBL27568818 0.81 NPC1 (0.40) LMNAKMT2AALDH1A1HPGDGAA
Hydrochloric Acid SCHEMBL9634743 0.80 ALDH1A1 (0.53) LMNAKMT2AALDH1A1HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4378936-A1 BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND AND USE THEREOF AS ANDROGEN RECEPTOR DEGRADER Hinova Pharmaceuticals Inc. (CN) 2024-06-05 EP claimed
CN-105287540-A Application of 7'-methyl-8'-chloro-2-hydroxy benzo [c] pyrido [4,3,2-mn] acridine-8-ketone in angiogenesis inhibition drug YANG YANG 2016-02-03 CN claimed
CN-105250281-A Application of 7'-methyl-8'-bromo-metoxybenzeneo[c]pyridineo[4,3,2-mn]acridine-8-one in angiogenesis inhibiting drugs YANG YANG 2016-01-20 CN claimed
CN-105250282-A Application of 7'-ethyl-8'-chlorine-3-hydroxyl benzo [c] pyridine [4,3,2-mn] acridine-8-ketone in angiogenesis inhibiting drug YANG YANG 2016-01-20 CN claimed
CN-102321084-B Method for synthesizing benzo[c]pyridine[4,3,2-mn]acridine-8-one NANJING UNIVERSITY OF TECHNOLOGY 2013-03-13 CN claimed
CN-102321084-A Method for synthesizing benzo[c]pyridine[4,3,2-mn]acridine-8-one NANJING UNIVERSITY OF TECHNOLOGY 2012-01-18 CN claimed
EP-1433785-A1 Agents for the coloration of keratinous fibres Henkel Kommanditgesellschaft auf Aktien (DE) 2004-06-30 EP claimed
US-6414152-B1 COMPOUND CAPABLE OF UNDERGOING LIGHT EMITTING REACTION IN PRESENCE OF DILUTE SOLUTION OF SODIUM HYDROXIDE AND HYDROGEN PEROXIDE, COMPRISING ACRIDINIUM CARBONYL MOIETY SUBSTITUTED WITH ARYL MOIETY HAVING ATTACHED REACTIVE GROUP UNIVERSITY OF WALES COLLEGE OF MEDICINE OF HEATH PARK (GB) 2002-07-02 US claimed
WO-1997027179-A2 ANTIRETROVIRAL BASES NOVARTIS AG (CH) 1997-07-31 WO claimed
EP-4378936-A1 BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND AND USE THEREOF AS ANDROGEN RECEPTOR DEGRADER Hinova Pharmaceuticals Inc. (CN) 2024-06-05 EP disclosed
US-20230096635-A1 CROSS-LINKED POLYMERIC MATERIALS, METHODS OF THEIR PREPARATION AND USES THEREOF THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2023-03-30 US disclosed
CN-115835751-A Organic light emitting diode and organic light emitting device including the same 乐金显示有限公司 2023-03-21 CN disclosed
EP-4100459-A1 CROSS-LINKED POLYMERIC MATERIALS, METHODS OF THEIR PREPARATION AND USES THEREOF The University of British Columbia (CA) 2022-12-14 EP disclosed
WO-2021155461-A1 CROSS-LINKED POLYMERIC MATERIALS, METHODS OF THEIR PREPARATION AND USES THEREOF THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2021-08-12 WO disclosed
US-6242188-B1 Sample processing to release nucleic acids for direct detection APPLIED GENE TECHNOLOGIES, INC. 2001-06-05 US disclosed
US-6239108-B1 Cell adhesion inhibitors BIOGEN, INC. 2001-05-29 US disclosed
CN-1282332-A Novel acronycine compounds, process for their preparation and pharmaceutical compositions containing them ADIR (FR) 2001-01-31 CN disclosed
US-5665606-A Method for assaying a substance using a polyacridinium compound KYOWA MEDEX CO., LTD. (JP) 1997-09-09 US disclosed
WO-1997027179-A2 ANTIRETROVIRAL BASES NOVARTIS AG (CH) 1997-07-31 WO disclosed
EP-0676641-A1 Method for assaying a substance KYOWA MEDEX CO., LTD. (JP) 1995-10-11 EP disclosed